AI Companies Run Virtual Drug Trials to Improve Human Study Success
· Technology · Reuters, The Independent
Artificial intelligence companies are increasingly running virtual drug trials using simulated patient data to predict clinical outcomes before testing on humans. The technology aims to identify potential flaws, toxicity issues, and efficacy problems early in the drug development pipeline. By filtering out unviable compounds digitally, developers hope to significantly improve the success rate of expensive and time-consuming human clinical trials. The initiative addresses the high attrition rate traditionally plaguing pharmaceutical research and development.
Why it matters
Could drastically reduce drug development costs and timelines for the pharmaceutical sector by filtering out failed compounds before physical trials begin.
Read the original report — Reuters
Join us on Telegram
Breaking news the moment it lands. At 10,000 members we ship the Android app.